positive
Sudeep Pharma IPO Attracts ₹268 Crore from Anchor Investors Ahead of Launch
Technology-driven excipients and specialty-ingredients maker Sudeep Pharma Ltd has secured ₹268 crore from anchor investors including Mukul Agrawal and Prashant Jain ahead of its ₹895 crore IPO opening on 21 November 2025. The strong anchor book bolsters market confidence in the issue, which includes a fresh issue of ₹95 crore and an Offer for Sale (OFS) component worth ~₹800 crore at the upper price band.
The company’s focus on pharma, food and nutrition market segments underpins investor interest.
Companies:
- Sudeep Pharma Ltd
Tags:
- ipo
- india
M• By Harsh Ranjan
Explore:High Return Equity Mutual Fund
positive
Sudeep Pharma IPO Attracts ₹268 Crore from Anchor Investors Ahead of Launch
Technology-driven excipients and specialty-ingredients maker Sudeep Pharma Ltd has secured ₹268 crore from anchor investors including Mukul Agrawal and Prashant Jain ahead of its ₹895 crore IPO opening on 21 November 2025. The strong anchor book bolsters market confidence in the issue, which includes a fresh issue of ₹95 crore and an Offer for Sale (OFS) component worth ~₹800 crore at the upper price band.
The company’s focus on pharma, food and nutrition market segments underpins investor interest.
Companies:
- Sudeep Pharma Ltd
Tags:
- ipo
- india
M• By Harsh Ranjan
Explore:High Return Equity Mutual Fund
1 min read
77 words
Sudeep Pharma raises ₹268 crore from anchor investors ahead of its ₹895 crore IPO opening 21 Nov.
Technology-driven excipients and specialty-ingredients maker Sudeep Pharma Ltd has secured ₹268 crore from anchor investors including Mukul Agrawal and Prashant Jain ahead of its ₹895 crore IPO opening on 21 November 2025. The strong anchor book bolsters market confidence in the issue, which includes a fresh issue of ₹95 crore and an Offer for Sale (OFS) component worth ~₹800 crore at the upper price band.
The company’s focus on pharma, food and nutrition market segments underpins investor interest.
Technology-driven excipients and specialty-ingredients maker Sudeep Pharma Ltd has secured ₹268 crore from anchor investors including Mukul Agrawal and Prashant Jain ahead of its ₹895 crore IPO opening on 21 November 2025. The strong anchor book bolsters market confidence in the issue, which includes a fresh issue of ₹95 crore and an Offer for Sale (OFS) component worth ~₹800 crore at the upper price band.
The company’s focus on pharma, food and nutrition market segments underpins investor interest.
Companies:
- Sudeep Pharma Ltd
Tags:
- ipo
- india
- ipo
- india
- pharma
- anchor_investors
- markets